Immunohistochemical detection indicated that α-Hederin (40 mg/kg) treatment increased Tunel and E-cad and suppressed Ki-67 and CD44 expression in xenograft tumor tissues (Figure 3C). The gene discussed is CD44; the disease is neoplasm.